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Background

Results

v Pre-term infants are at risk of hypoglycemia and therefore
require timely feedings and monitoring of serum glucose
levels
v Infants diagnosed with hypoglycemia are associated with
an increased risk for adverse neurodevelopmental
outcomes
v Interventions within the golden hour have been shown to
reduce adverse neonatal outcomes

v Study the incidence of hypoglycemia at admission in ELBW
(birth weight ≤1000 g) infants,
v Study the percentage of infants who had blood glucose
determination and received IV glucose within the golden
hour,
v Assess clinical outcomes at discharge between
hypoglycemic vs euglycemic infants.
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v Time to first blood glucose determination
• Median (IQR): 56 (45-73) minutes
• 145 (59%) of all infants tested within first hour of life
•190/244 infants had glucose determination before IV glucose
initiation
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Purpose of Study

v 244 infants enrolled birth weight of ≤1000g
v Mean ± SD GA: 26.2 ± 2.4 weeks
v Mean ± SD birth weight: 739 ± 161g

Time to Blood Glucose determination and IV Glucose
Administration in ELBW Infants (n=244)
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v Time to administration of IV fluids or given bolus dextrose
• Median (IQR): 88 (60-120) minutes
• 59 (24%) given within an hour of life
v 123 (51%) had hypoglycemia (<47mg/dL)
v 91 (37%) had severe hypoglycemia (<40mg/dL)
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Methods Used
Data were collected and analyzed from 244 ELBW infants
born between 2017-2020 at the Regional One Health NICU.
Hypoglycemia is defined as glucose level of <47 mg/dL.
Severe hypoglycemia is defined 40mg/dL.
Data Collected:
v Time to first blood glucose determination
v Time of first IV glucose administration (bolus and/or IV
dextrose infusion)
v Demographic characteristics
v Maternal history
v Birth history
v Outcomes at discharge
Statistical significance was determined with chi-squared
analysis and t-tests.
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Clinical Data for Infants with Severe Hypoglycemia
Initial Blood Glucose Level
<40mg/dL
≥40mg/dL
n=91
n=153
Gestational age (weeks) *
27±2
26 ±2
Birth Weight (grams) *
721±172
745 ± 147
IUGR
44 (48%)
33 (22%)
Race
African American
82 (90%)
123 (80%)
Caucasian
9 (10%)
29 (19%)
Mode of Delivery
Vaginal Delivery
14 (15%)
48 (31%)
C-section
77 (85%)
105 (69%)
Beta Blocker therapy
19 (21%)
8 (5%)
Chorioamnionitis
17 (19%)
72 (47%)
* Mean ±SD

p value

v Significant risk factors for severe hypoglycemia: C-section, IUGR, and βBlocker use, (all had p<0.005).
v The composite mortality and/or major morbidity (BPD, ROP, NEC, HAI and
neurological symptoms which included seizures, jitters, tremors adverse
neurological sequelae), did not significantly differ between severely
hypoglycemic and euglycemic infants.
v Euglycemic and hypoglycemic infants showed no difference in incidence of
maternal diabetes, hypothermia on admission, Apgar scores, and use of
antenatal cortical steroids
v Maternal Chorioamnionitis decreases the risk of severe hypoglycemia.
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Conclusions
v Incidence of hypoglycemia on admission is high among ELBW infants,
and administration of IV glucose is often delayed beyond an hour of life.
v All ELBW infants need to be screened for hypoglycemia and provided IV
glucose within an hour after birth.
v We have started a QI initiative to improve glucose monitoring and IV
glucose administration during the golden hour

